medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2020, Number 2

<< Back Next >>

Cir Plast 2020; 30 (2)

The importance of reducing the viral load to diminish the risk of COVID-19 spread

Cuenca-Pardo J, Ramos-Gallardo G, Vélez-Benítez E, Álvarez-Díaz CJ, Bucio-Duarte J, Iribarren-Moreno R, Rodríguez-Marín D, Contreras-Bulnes L

Language: Spanish
References: 112
Page: 78-93
PDF size: 929.85 Kb.


ABSTRACT

We carried out a systematic review on the importance of reducing viral load, as a strategy to reduce the risk of infection or to diminish the severity of the disease. We selected 113 publications and analyzed the theoretical concepts and recommendations we made with the best medical evidence available. Viral load is related to the attack rate and severity of COVID 19. It has been recognized that the production of aerosols is the main source of contagion among health personnel. The risk of contagion is higher in closed and poorly ventilated spaces, where people stay with several individuals for a long time, without due distance and without protection. The contagion rate is higher than 80% and there is a very high mortality. Another source of super spread occurs among health personnel who must care for COVID patients for long periods of time, and inhale their respiratory secretions, without having appropriate protective equipment. Surgeons and other professionals must attend the public: unknown people who may be carriers of the virus; therefore, are exposed to contagion. The main preventive protection that will help us reduce the viral load is: the widespread use of masks, eye protection, distancing, hand hygiene and sanitation of the environment. Even though there is a lack of evidence regarding their effectiveness, these should be used for precaution and must be compulsory and universal.


REFERENCES

  1. Franco AE, Serrano R, Gimeno A, De Juan J, Merino E, Jiménez del Cerro L et al. Estudio de carga viral y antigenemia como valores predictivos de recidiva de infección CMV en el trasplante renal. Nefrología 2007; 27 (2): 202-208.

  2. Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 2020; 20 (6): 656-657. doi: 10.1016/S1473-3099(20)30232-2.

  3. PCR cuantitativa para la detección de la carga viral. Disponible en: https://www.empireo.es/enfermedadestransmisionsexual/prueba-de-vih/vih-cuantitativa/

  4. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020; 323 (14): 1406-1407. doi: 10.1001/jama.2020.2565.

  5. To KK, Tsang OT, Leung WS, Tam AR, Wu TC et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20 (5): 565-574. doi: 10.1016/S1473-3099(20)30196-1.

  6. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020; 25 (10): 2000180. doi: 10.2807/1560-7917.ES.2020.25.10.2000180.

  7. Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 2020; 369: m1443. doi: 10.1136/bmj.m1443.

  8. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020; 26 (8): 1200-1204. doi: 10.1038/s41591-020-0965-6.

  9. European Centre for Disease Prevention and Control (ECDC). Situation update worldwide [cited 2020 1 March]. Available from: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.

  10. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020; 323 (15): 1488-1494. doi: 10.1001/jama.2020.3204.

  11. Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev 2020; 34 (2): 75-80.

  12. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506.

  13. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill 2020; 25 (5): 2000062. doi: 10.2807/1560-7917.ES.2020.25.5.2000062.

  14. Peng L, Liu J, Xu W, Luo Q, Deng K, Lin B et al. 2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples. medRxiv 2020. doi: https://doi.org/10.1101/2020.02.21.20026179

  15. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S, Hayashi K et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020; 94: 154-155. doi: 10.1016 / j.ijid.2020.03.020.

  16. Wu Z, McGoogan J. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13):1239-1242. doi: 10.1001/jama.2020.2648.

  17. Chen N, Zhou M, Dong X, Qu JM, Gong FY, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513. doi: 10.1016/s0140-6736(20)30211-7.

  18. Luo SH, Liu W, Liu ZJ, Zheng XY, Hong CX, Liu ZR et al. A confirmed asymptomatic carrier of 2019 novel coronavirus. Chin Med J (Engl) 2020; 133 (9): 1123-1125. doi: 10.1097/CM9.0000000000000798.

  19. INFOBAE. ¿Cómo nos contagiamos de COVID-19? Julio 2020. Disponible en: https://www.infobae.com/america/mundo/2020/06/25/como-nos-contagiamos-coronavirus-entre-los-expertos-hay-cada-vez-mas-consensos/.

  20. El supercontagio en esta pandemia podría ser una buena noticia. Julio 2020. Disponible en: https://www.nationalgeographic.com.es/ciencia/supercontagio-esta-pandemia-podria-ser-buena-noticia_15594.

  21. Pérez Caballero J. Sobre el uso popular del término "súper propagador" del COVID-19. El Catoblepas 2020; 191: 33.

  22. Enfermedad por Coronavirus, COVID 19. Actualización 3 de julio de 2020. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/ITCoronavirus.pdf.

  23. Edwards SP, Kasten S, Nelson C, Elner V, McKean E. Maxillofacial trauma management during COVID-19: multidisciplinary recommendations. Facial Plast Surg Aesthet Med 2020; 22 (3): 157-159. doi: 10.1089 / fpsam.2020.0158.

  24. Givi B, Schiff BA, Chinn SB, Clayburgh D, Iyer NG, Jalisi S et al. Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic. JAMA Otolaryngol Head Neck Surg 2020; 146 (6): 579-584. doi: 10.1001/jamaoto.2020.0780.

  25. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323 (11): 1061-1069. doi: 10.1001/jama.2020.1585.

  26. Hill DS, O’Neill JK, Powell RJ, Oliver DW. Surgical smoke a health hazard in the operating theatre: a study to quantify exposure and a survey of the use of smoke extractor systems in UK plastic surgery units. J Plast Reconstr Aesthet Surg 2012; 65: 911-916.

  27. Ragde SF, Jorgensen RB, Foreland S. Characterization of exposure to ultrafine particles from surgical smoke by use of a fast mobility particle sizer. Ann Occup Hyg 2016; 60 (7): 860-874.

  28. Kwak HD, Kim SH, Seo YS, Song KJ. Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Occupy Environ Med 2016; 73: 857-863.

  29. Vourtzoumis P, Alkhamesi N, Elnahas A. Operating during COVID-19: is there a risk of viral transmission from surgical smoke during surgery? Can J Surg 2020; 63 (3): E299-E301.

  30. Zhu N, Zhang D, Wang W, Li X, Yang B. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727-733. doi: 10.1056 / NEJMoa2001017.

  31. Mowbray N, Ansell J, Warren N, Wall P, Torkington J. Is surgical smoke harmful to theater staff? A systematic review. Surg Endosc. 2013; 27 (9): 3100-3107.

  32. Mowbray NG, Ansell J, Horwood J, Cornish J, Rizkallah P, Parker A et al. Safe management of surgical smoke in the age of COVID-19. Br J Surg 2020; 107 (11): 1406-1407. doi: 10.1002/bjs.11679.

  33. Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020; 5 (9): e475-e483. doi: 10.1016/S2468-2667(20)30164-X.

  34. Stahel PF. How to risk-stratify elective surgery during the COVID-19 pandemic? Patient Saf Surg 2020; 14: 8. doi: 10.1186/s13037-020-00235-9.

  35. McKay B, Calfas J, Ansari T. Coronavirus declared pandemic by World Health Organization. Wall St J 2020.

  36. Commins J. Surgeon general urges providers to consider stopping all elective surgeries – hospitals push back. Health Leaders 2020.

  37. Evans M, Wilde MA. Hospitals push off surgeries to make room for coronavirus patients. Wall St J 2020.

  38. Martines J. UPMC shuns health experts’ calls to cancel elective surgeries. Pittsburgh Tribune-Review 2020.

  39. Barnes M, Sax PE. Challenges of "return to work" in an ongoing pandemic. New Engl J Med 2020; 383: 779-786. doi: 10.1056/NEJMsr2019953.

  40. SaifAddin BK, Almogbel AS, Zollner CJ, Wu F, Bonef B, Iza M et al. AIGaN deep ultraviolet light-emitting diodes grown on SiC substrates. ACS Photonics 2020; 7: 554-561. doi: 10.1021/acsphotonics.9b00600.

  41. Ultraviolet LEDs prove effective in eliminating coronavirus from surfaces and, potentially, air and water. Science Daily. 2020. Disponible en: https://www.science daily.com/releases/2020/04/200414173251

  42. Cochrane Iberoamérica. ¿Está justificado el uso generalizado de mascarillas para evitar la transmisión comunitaria del nuevo coronavirus? 19 de abril de 2020. Disponible en: https://es.cochrane.org/es/%C2%BFest%C3%A1-justificado-el-uso-generalizado-de-mascarillas-para-evitar-la-transmisi%C3%B3n-comunitaria-del

  43. Coronavirus: mascarillas y evidencias científicas. Urgencias y emergencias. Actualización 22 de junio de 2020. Disponible en: https://www.urgenciasyemergen.com/coronavirus-mascarillas-y-evidencia-cientifica/

  44. Gandhi M, Beyrer Ch, Goosby E. Masks do more than protect others during COVID-19: reducing the inoculum of SARS-CoV-2 to protect the wearer. J Gen Inter Med 2020. doi: 10.1007/s11606-020-06067-8.

  45. Fennelly K. Particle size of infectious aerosols: implications for infection control. Lancet Resp Med 2020. doi: 10.1016/S2213-2600(20)30323-4.

  46. Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. JAMA 2020. doi: 10.1001/jama.2020.4756.

  47. Tang JW, Settles GS. Images in clinical medicine. Coughing and aerosols. N Engl J Med 2008; 359: e19.

  48. Xie X, Li Y, Chwang AT, Ho PL, Seto WH. How far droplets can move in indoor environments-revisiting the Wells evaporation falling curve. Indoor Air 2007; 17: 211-225.

  49. Bahl P, Doolan C, De Silva C, Chughtai AA, Bourouiba L, Macintyre CR. Airborne or droplet precautions for health workers treating COVID-19? J Infect Dis 2020. doi: 10.1093/infdis/jiaa189.

  50. Lindsley WG, Noti JD, Blachere FM, Szalajda JV, Beezhold DH. Efficacy of face shields against cough aerosol droplets from a cough simulator. J Occup Environ Hyg 2014; 11: 509-518.

  51. Dharmadhikari AS, Mphahlele M, Stoltz A et al. Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward. Am J Resp Crit Care Med 2012; 185: 1104-1109.

  52. Wood ME, Stockwell RE, Johnson GR et al. Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis. Am J Resp Crit Care Med 2018; 197: 348-355.

  53. Prather KA, Wang CC, Schooley RT. Reducing transmission of SARS-CoV-2. Science 2020; 368: 1422-1424.

  54. Worldometer. COVID-19 coronavirus pandemic. 2020. Disponible en: https://www.worldometers.info/coronavirus/

  55. Guo ZD, Wang ZY, Zhang SF et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis 2020. doi: 10.3201/eid2607.200885.

  56. Chia PY, Coleman KK, Tan YK, Ong SWX, Gum M, Lau SK et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat Commun 2020; 11 (1): 2800. doi: 10.1038/s41467-020-16670-2.

  57. Santarpia JL, Rivera DN, Herrera V et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the University of Nebraska Medical Center. medRxiv 2020. doi: 10.1101/2020.03.23.20039446.

  58. Cheng V, Wong SC, Chen J et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol 2020; 41: 493-498.

  59. Wong SCY, Kwong RTS, Wu TC et al. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect 2020; 105: 119-127.

  60. Faridi S, Niazi S, Sadeghi K et al. A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran. Sci Total Environ 2020; 725: 138401.

  61. Ong SWX, Tan YK, Chia PY et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020; 323: 1610-1612.

  62. Qualls N, Levitt A, Kanade N et al. Community mitigation guidelines to prevent pandemic influenza: United States, 2017. MMWR Recomm Rep 2017; 66: 1-34.

  63. Feng S, Shen C, Xia N, Song W, Fan M, Cowling BJ. Rational use of face masks in the COVID-19 pandemic. Lancet Resp Med 2020; 8: 434-436.

  64. MacIntyre R, Chughtai A, Tham CD, Seale H. COVID-19: should cloth masks be used by healthcare workers as a last resort? BMJ 2020. Disponible en: https://blogs.bmj.com/bmj/2020/04/09/covid-19-should-cloth-masks-be-used-by-healthcare-workers-as-a-last-resort/

  65. Jefferson T, Jones M, Al Ansari LA, Bawazeer G, Beller E, Clark J et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 - Face masks, eye protection and person distancing: systematic review and meta-analysis. medRxiv 2020. doi: https://doi.org/10.1101/2020.03.30.20047217.

  66. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ; COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020; 395 (10242): 1973-1987. doi: 10.1016/S0140-6736(20)31142-9.

  67. Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, van der Westhuizen H et al. Face masks against COVID-19: an evidence review. Preprints 2020; 2020040203 doi: 10.20944/preprints202004.0203.v1.

  68. Brainard JS, Jones N, Lake I, Hooper L, Hunter P. Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review. medRxiv 2020. doi: 10.1101/2020.04.01.20049528.

  69. Greenhalgh T, Schmid MB, Czypionka T, Bassler D, Gruer L. Face masks for the public during the covid-19 crisis. Br Med J 2020; 369: m1435. doi: 10.1136/bmj.m1435.

  70. WHO Health Emergencies Preparedness and Response Team. Advice on the use of masks in the context of COVID-19. 2020. WHO reference number WHO/2019-nCov/IPC_Masks/2020.3.

  71. WHO. Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza. 2019. ISBN: 978-92-4-151683-9.

  72. Recommendation Regarding the Use of Cloth Face Coverings, Especially in Areas of Significant Community-Based Transmission. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/prev

  73. https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-and-face-masks

  74. https://www.nelsonlabs.com/testing/bacterial-viral-filtration-efficiency-bfe-vfe

  75. http://www.dof.gob.mx/normasOficiales/3926/stps3/stps3.htm

  76. https://multimedia.3m.com/mws/media/1791500O/comparison-ffp2-kn95-n95-filtering-facepiece-respirator-classes-tb.pdf

  77. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html

  78. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidppe

  79. https://higieneambiental.com/aire-agua-y-legionella/higiene-de-las-manos-para-prevenir-el-covid-19. 20 de marzo de 2020.

  80. https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/advice-for-public. https://www.paho.org/es/eventos/agua-saneamiento-lavado-manos-entornos-educativos-retos-oportunidades-tiempos-covid-19

  81. https://www.campusvirtualsp.org/es/curso/covid-19-precauciones-basicas-higiene-de-las-manos-2020

  82. https://espanol.cdc.gov/coronavirus/2019-ncov/community/reopen-guidance.html. 7 may 2020

  83. https://espanol.cdc.gov/coronavirus/2019-ncov/community/organizations/cleaning-disinfection.html

  84. https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2

  85. https://www.bphc.org/whatwedo/infectious-diseases/Infectious-Diseases-A-to-Z/Documents/Cleaning%20and%20Disinfecting%20for%20COVID%2019%20-%20spanish.pdf

  86. Buonanno M, Welch D, Shuryak I, Brenner DJ. La luz UVC lejana (222 nm) inactiva de manera eficiente y segura los coronavirus humanos en el aire. Informes Científicos 2020; 10 (1). doi: 10.1038/s41598-020-67211-2.

  87. Martínez-Sánchez G, Schwartz A, Donna VD. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel) 2020; 9 (5): 389.

  88. Marconcini S, Giammarinaro E, Covani U. The timeliness of ozone in the COVID era. Eur Rev Med Pharmacol Sci 2020; 24 (9):4625-4626.

  89. Hernández A, Papadakos PJ, Torres A, González DA, Vives M, Ferrando C et al. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev Esp Anestesiol Reanim 2020; 67 (5): 245-252.

  90. Wang J, Shen J, Ye D, Yan X, Zhang Y, Yang W et al. Disinfection technology of hospital wastes and wastewater: Suggestions for disinfection strategy during coronavirus Disease 2019 (COVID-19) pandemic in China. Environ Pollut 2020; 262: 114665.

  91. Rubio-Romero JC, Pardo-Ferreira MDC, Torrecilla-García JA, Calero-Castro S. Disposable masks: Disinfection and sterilization for reuse, and non-certified manufacturing, in the face of shortages during the COVID-19 pandemic. Saf Sci 2020; 129: 104830.

  92. Dev Kumar G, Mishra A, Dunn L, Townsend A, Oguadinma IC, Bright KR et al. Biocides and novel antimicrobial agents for the mitigation of coronaviruses. Front Microbiol 2020; 11: 1351.

  93. Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res 2017; 7: 212-219.

  94. Rowen RJ, Robins H, Carew K, Kamara MM, Jalloh MI et al. Rapid resolution of hemorrhagic fever (Ebola) in Sierra Leone with Ozone therapy. Afr J Infect Dis 2016; 10(1): 49-54.

  95. Rowen RJ, Robins HR. A plausible "penny" costing effective treatment for corona virus-Ozone Therapy. J Infect Dis Epidemiol 2020; 6: 113.

  96. Elvis AM, Ekta JS. Ozone therapy: A clinical review. J Nat Sci Biol Med 2011; 2 (1): 66-70.

  97. Ricevuti G, Franzini M, Valdenassi L. Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures. Ozone Ther 2020; 5: 9014.

  98. Semple JL, Moore GWK. High levels of ambient ozone (O3) may impact COVID-19 in high altitude mountain environments. Respir Physiol Neurobiol 2020; 280: 103487. doi: 10.1016/j.resp.2020.103487.

  99. Silva EJNL, Prado MC, Soares DN, Hecksher F, Martins JNR, Fidalgo TKS. The effect of ozone therapy in root canal disinfection: a systematic review. Int Endod J 2020; 53 (3): 317-332.

  100. Gérard V, Sunnen MD. SARS and ozone therapy: Theoretical considerations [cited in 2003]. Available from: http://www.triroc.com/sunnen/topics/sars.html

  101. Tirelli U, Cirrito C, Pavanello M, Piasentin C, Lleshi A, Taibi R. Ozone therapy in 65 patients with fibromyalgia: an effective therapy. Eur Rev Med Pharmacol Sci 2019; 23: 1786-1788.

  102. Murray BK, Ohmine S, Tomer DP, Jensen KJ, Johnson FB, Kirsi JJ et al. Virion disruption by ozone-mediated reactive oxygen species. J Virol Methods 2008; 153 (1): 74-77.

  103. Alzain S. Effect of chemical, microwave irradiation, steam autoclave, ultraviolet light radiation, ozone and electrolyzed oxidizing water disinfection on properties of impression materials: a systematic review and meta-analysis study. Saudi Dent J 2020; 32 (4): 161-170.

  104. Leon OS, Menendez S, Merino N, Castillo R, Sam S, Perez L et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 1998; 7 (4): 289-294.

  105. Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol 2020; 92 (11): 2348-2350.

  106. Ricevuti G, Franzini M, Valdenassi L. Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures. Ozone Ther 2020; 5: 9014.

  107. Guía sobre el uso del equipo de protección personal durante la pandemia COVID-19. Instituto Nacional de Ciencias Médicas y Nutrición Doctor Salvador Zubirán. Actualizado 27 abril 2020. Disponible en: http://www.incmnsz.mx/2020/Guia-equipo-de-proteccion-INCMNSZ.pdf

  108. Lineamiento técnico de uso y manejo del equipo de protección personal ante la pandemia por COVID-19. Gobierno de México [actualizado 12 de mayo de 2020]. Disponible en: https://coronavirus.gob.mx/wp-content/uploads/2020/05/Lineamiento_uso_manejo_EPP

  109. Guidance on Preparing Workplace for COVID 19. US department of labor. Disponible en: https://www.osha.gov/Publications/OSHA3990.pdf

  110. Casas MML, Portes-Castro MA. Bioética y trasplantes electivos. Principio de proporcionalidad terapéutica. Cir Plast 2010; 20 (1): 43-48.

  111. https://es.wikipedia.org/wiki/Principio_de_precauci%C3%B3n

  112. Sánchez E. El principio de precaución: implicaciones para la salud Pública. Gac Sanit 2002; 16 (5). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112002000500001




2020     |     www.medigraphic.com